Skip to main content
. 2015 Jun 12;59(7):4129–4138. doi: 10.1128/AAC.04049-14

FIG 3.

FIG 3

Maximum serum concentrations (Cmax) of para-aminosalicylic acid in patients with tuberculosis receiving either 4 g granular slow-release para-aminosalicylic acid twice daily or 8 g once daily and the influence of the NAT1*10 (A), NAT1*14A (B), NAT2*5 (C), and NAT2*6 (D) alleles during a randomized crossover study.